Amgen biosimilar debut boosted by UnitedHealthcare coverage switch

UnitedHealthcare will preferentially cover lower-cost versions of Roche's top-selling cancer drugs, helping Amgen's efforts to gain market share. 

Source: Healthcare Dive, https://www.healthcaredive.com